![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Advertisement
Persons > All
France
Monaco
Central France
Eastern France
Northern France
Paris (region)
Southern France
Western France
Find below all kinds of persons from France & Monaco.Total search results: 2358 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Baran, Michael (Pfizer 201912 Principal at Pfizer Ventures + Exec Director External Science + Innovation) | Principal (venture capital) | Pfizer (Group) | |
| Baratte, Sophie (Cellnovo 201602 CEO) | Chief Executive Officer (CEO) | Cellnovo (Group) | Île-de-France (region) |
| Barbaroux, Jean-Baptiste (Global Bioenergies 201710 Heead of Corporate Development) | Business Development Manager / Strategy Manager | Global Bioenergies (Group) | Île-de-France (region) |
| Barbazette, Chris (DNA Script 2ß22ß5– CCO before Resolve Biosciences + EAB Consulting + GenapSys + Agendia + Affymetrix) | Chief Commercial Officer (CCO) | Resolve Biosciences GmbH | Nordrhein-Westfalen (federal state) |
| Barcella, Michela (Panakès Partners 202310– Network + Portfolio Talent Manager before H-FARM College) | Human Resources Manager | Panakès Partners (Group) | Lombardia (Lombardy) |
| Barfod, Lars (Elsevier MDL 200510 CEO) | Chief Executive Officer (CEO) | Dassault Systèmes (3DS) (Group) | California (federal state) |
| Barillot, Emmanuel (Institut Curie 200604 Director Bioinformatics) | n. a. | Institut Curie | Île-de-France (region) |
| Barlesi, Fabrice (Gustave Roussy 202312 General Director + CEO of Gustave Roussy Transfert) | President/Director/Head Business Group/Unit/Division | Gustave Roussy (Group) | Île-de-France (region) |
| Barner, Andreas (Boehringer) | Board member | Boehringer Ingelheim (Group) | Rheinland-Pfalz (federal state) |
| Barnes, Jonae R. (Poxel 201704 SVP IR + PR before Sepracor 200601 VP Investor Relations) | Public Relations Manager / Investor Relations Manager | Dainippon Sumitomo (Group) | Massachusetts (federal state) |
| Barratte, Sophie (CIT 201011 Managing Director) | Managing Director | CiToxLab (Group) | France (region/state unspecified) |
| Barrett, Elizabeth (Liz) (UroGen 201901– CEO before CEO Novartis Oncolgoy + Pfizer + Cephalon + JnJ) | Chief Executive Officer (CEO) | UroGen Pharma Ltd. (Nasdaq: URGN) | Israel_o |
| Barrette, Kate (RooneyPartners) | Public Relations Manager / Investor Relations Manager | RooneyPartners (Rooney & Associates) | New York (federal state) |
| Barrier, Denis (Cathay Capital 202108 Managing Partner plus CEO + Co-Founder of Cathay Innvoation) | Managing Partner (investment firm) | Cathay Capital (Group) | Île-de-France (region) |
| Barteau, Benoit (France (govt) 201904 Senior Investment Manager at BPI France) | Investment Manager | France (govt) | Île-de-France (region) |
| Barthelemy, Nicolas (Invitrogen 200701 Senior VP Cell Culture Systems div) | n. a. | Thermo Fisher (Group) | California (federal state) |
| Bartlett, Alan (CiToxLab 201609– Senior Director Global Lab Operations before CTBR/Charles River Montreal + SafePharm) | Laboratory Manager (industry) | CiToxLab (Group) | Québec |
| Barton, Warren (Génome Express 200503 CEO) | Chief Executive Officer (CEO) | Clinical Data (Group) | France (region/state unspecified) |
| Bartonícek, Ladislav (PPF Group 201502 Board Member responsible for biotechnology) | Board member, executive | PPF Group (Group) | North Holland (province, NL) |
| Basler, Marie (BioValley France 202309 Digital Project Manager) | Cluster Manager | BioValley France | Grand Est (Great East) (region) |
| Bastian, Helge (Thermo Fisher 201406 General Manager Synthetic Biology before Indivumed + Sigma-Aldrich + SGS + Qiagen) | Managing Director | Thermo Fisher (Group) | Massachusetts (federal state) |
| Bastianelli, Enrico (Bone Therapeutics 2006c–201610 CEO RESIGNED 10/16) | Chief Executive Officer (CEO) | Bone Therapeutics (Group) | Wallonia (region) |
| Bastianelli, Giacomo (Meiogenix 201604 CEO + Co-Founder) | Chief Executive Officer (CEO) | Meiogenix SAS | Île-de-France (region) |
| Bastid, Jérémy (Orega Biotech 201601 COO) | Chief Operating Officer (COO) | Orega Biotech (FR) | Auvergne-Rhône-Alpes (region) |
| Bastid, Pierre | n. a. | ||
| Bauer, Grégory (Atlanpole 201411 International Marketing Manager at Atlanpole Biotherapies) | Cluster Manager | Atlanpole (FR) | Pays de la Loire (region) |
| Bauler, James (Flag Therapeutics 201901 Director Corporate Development) | Business Development Manager / Strategy Manager | Flag Therapeutics (US) | North Carolina (federal state) |
| Bault, Laurence (Huntsworth 201506 at Citigate Dewe Rogerson Paris) | Public Relations Manager / Investor Relations Manager | Inizio (Group) | Île-de-France (region) |
| Baum, Binah (Alma Bio Therapeutics 201706 CEO + Co-Founder) | Chief Executive Officer (CEO) | Alma Bio Therapeutics S.A.S | Auvergne-Rhône-Alpes (region) |
| Baumert, Thomas F. (Univ Stasbourg 201904 Professor + Scientific Founder of Alentis Therapeutics) | Professor | University of Strasbourg | Grand Est (Great East) (region) |
| Baumont, Sophie (Cohesion Bureau 202307 before LifeSci 202106 at LifeSci Advisors) | Public Relations Manager / Investor Relations Manager | BioConfidant (Group) | Région Lémanique (region) |
| Bavière, Christophe (Idinvest Partners 201812 CEO) | Chief Executive Officer (CEO) | Eurazeo (Group) | Île-de-France (region) |
| Bayec, Pauline (Global Bioenergies 202110 Head of IR + Corp Communciations) | Public Relations Manager / Investor Relations Manager | Global Bioenergies (Group) | Île-de-France (region) |
| Bazantay, Christian (Servier 201110 Managing Director of Servier Deutschland GmbH) | Managing Director | Servier (Group) | Bayern (federal state) |
| Beaumont, Sophie (LifeSci Advisors 202101) | Public Relations Manager / Investor Relations Manager | LifeSci (Group) | New York (federal state) |
| Béchard, David (Cytune Pharma 201502 President + Founder) | Chief Executive Officer (CEO) | Cytune Pharma SAS | Pays de la Loire (region) |
| Béchon, Christian (France (govt) 201508 CEO of LFB + France Biotech 201508 Board Director) | Chief Executive Officer (CEO) | France (govt) | Île-de-France (region) |
| Beck, Jürgen (Memo Therapeutics 202306 CMO before prosion + Paion + Intermune + Epigenomics + Synthélabo) | Chief Medical Officer (CMO) | Memo Therapeutics AG (MTx) | Zürich (region) |
| Beckerling, Andree (Accovion 201504 Managing Director (CEO)) | Managing Director | Clinipace (Group) | Hessen (Hesse) (federal state) |
| Beeler, Kristina (Biognosys 202105– CBO before Head of Business Development joined 2017 before Nextech Invest) | Chief Business Officer (CBO) | Bruker (Group) | Zürich (region) |
| Beerman, Noah D. (Poxel 201505– EVP BusDev + President US before Coronado Biosciences + RXi Pharmaceuticals + Indevus) | Business Development Manager / Strategy Manager | Galena BioPharma Inc. | Massachusetts (federal state) |
| Beguir, Karim (InstaDeep 202011 CEO + Co-Founder) | Chief Executive Officer (CEO) | BioNTech (Group) | Greater London (region) |
| Behar, Greg (Recipharm 202401– CEO before CEO of Nestlé Health Science before Novartis + Boehringer Ingelheim) | Chief Executive Officer (CEO) | Recipharm (Group) | Sweden_o |
| Beher, Dirk (Asceneuron 201509 CEO) | Chief Executive Officer (CEO) | Asceneuron S.A. | Région Lémanique (region) |
| Behrenbruch, Christian (Telix 201511– CEO before ImaginAb CEO + Co-Founder) | Chief Executive Officer (CEO) | Telix Pharmaceuticals Ltd. (ASX: TLX) | Victoria (VIC) |
| Bekkali, Soraya (Cellinta 202007– CEO before Gyroscope Therapeutics + Lysogene + Orphan Europe + Sanofi) | Chief Executive Officer (CEO) | Cellinta Ltd. | Greater London (region) |
| Belichard, Pierre (Enterome 201203 CEO) | Chief Executive Officer (CEO) | Enterome S.A. | Île-de-France (region) |
| Bélingard, Jean-Luc (Mérieux 201101– Président Directeur Général before Ipsen CEO + Pierre Fabre + Roche Diagnostics) | President/Director/Head Business Group/Unit/Division | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Belissa-Mathiot, Patricia (Servier 201307 Director of Rheumatology Innovative Pole) | Research & Development Manager | Servier (Group) | Île-de-France (region) |
| Bell, Deborah (Instinctif Partners 201902) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | Greater London (region) |
| Bellemin, Jean-Marc (Gritsone Oncology 201801– CFO before Actelion + Guerbet) | Chief Financial Officer (CFO) | Gritstone Oncology Inc. | California (federal state) |
| Bellocq, Chloé (In-Cell-Art 200709– CEO) | Chief Executive Officer (CEO) | In-Cell-Art SAS | Pays de la Loire (region) |
| Belot, Benjamin (Kurma Partners 202011 Partner before Zuellig Pharma + Janssen +Alcimed) | Partner (venture partner) | Eurazeo (Group) | Île-de-France (region) |
| Belot, Eric (Neuroptis Biotech 201210 CEO) | Chief Executive Officer (CEO) | Neuroptis Biotech (FR) | Île-de-France (region) |
| Beltzung, Lise (Andrew Lloyd 201510 Consultant) | Public Relations Manager / Investor Relations Manager | Andrew Lloyd & Associates (ALA) | Île-de-France (region) |
| Ben Brahim, Hedi (Transgene 202101–202305 CEO before Institut Mérieux + Vallourec + France (govt) RETIRED 6/23) | Chief Executive Officer (CEO) | Mérieux (Group) | Grand Est (Great East) (region) |
| Ben-Moshe, Tehila (Biond Biologics 202101 CEO + Co-Founder) | Chief Executive Officer (CEO) | Biond Biologics Ltd. | Israel_o |
| Benanou, David (Veolia 201407) | n. a. | Veolia (Group) | Île-de-France (region) |
| Bencteux, Philippe (Robocath 2009– Chairman + Founder) | Board member | Robocath SAS | Normandie (Normandy) (region) |
| Benedict, Nicholas (Vaderis Therapeutics 202208 CEO + Co-Foudner formerly Allecra Therapeutics) | Chief Executive Officer (CEO) | Vaderis Therapeutics AG | Northwestern Switzerland (region) |
| Benefiel, Monty (Agilent 201506 Division General Manager Mass Spec before 201302 VP for gas phase systems) | President/Director/Head Business Group/Unit/Division | Agilent (Group) | California (federal state) |
| Benhamou, Pierre-Henri (DBV Technologies 201508 CEO + Board Director of Biotech France) | Chief Executive Officer (CEO) | DBV Technologies S.A. (Euronext Paris: DBV + Nasdaq Global Select Market: DBVT) | Île-de-France (region) |
| Benioff, Marc (Salesforce 202012 CEO) | Chief Executive Officer (CEO) | Salesforce.com Inc. (NYSE: CRM) | California (federal state) |
| Bennani, Youssef (Domain Therapeutics 202205 Board Chairman) | Board member, non-executive | Domain Therapeutics (Group) | Grand Est (Great East) (region) |
| Bensimon, Aaron (Genomic Vision 201107 CEO + founder) | Chief Executive Officer (CEO) | Genomic Vision S.A. (Euronext Paris: GV) | Île-de-France (region) |
| Bérenger, Maurice (CardioRenal SAS 201708 CEO) | Chief Executive Officer (CEO) | CardioRenal SAS | France (region/state unspecified) |
| Béret, Antoine (Axenis 201809 Board Chairman before co-founder + CEO Immunotech + Trophos CEO of TxCell) | Chief Executive Officer (CEO) | genOway (Group) | Île-de-France (region) |
| Berg, Christan (Alice RP 201310) | public relations / investor relations | Alize RP (Public Relations) | Île-de-France (region) |
| Berg, Susan (Agilent 201311–201410 Global Public Relations Life Sciences/Chemical Analysis Group LEFT 10/14) | public relations / investor relations | Agilent (Group) | California (federal state) |
| Berghorn, Rebecca (Definiens 201310– Director Clinical Product Marketing before MeVis Medical) | Sales Manager / Marketing Manager | AstraZeneca (Group) | Bayern (federal state) |
| Berka, Klaus (Analytik Jena 200702 Chairman Executive Board) | Chief Executive Officer (CEO) | Endress+Hauser (Group) | Thüringen (federal state) |
| Bernal, Savita (MaaT Pharma 202005– CBO before Adocia + e(ye)BRAIN + Ernst & Young Paris) | Chief Business Officer (CBO) | MaaT Pharma (Microbiota as a Therapy) (Euronext: MAAT) | Auvergne-Rhône-Alpes (region) |
| Bernard, Thierry (Qiagen 201502– SVP Molecular Dx business area before bioMérieux Corp VP Commcercial Operations) | President/Director/Head Business Group/Unit/Division | Qiagen (Group) | Limburg (province, NL) |
| Berrebi, Sylvie (Huntsworth 201506 at Citigate Dewe Rogerson) | Public Relations Manager / Investor Relations Manager | Inizio (Group) | Greater London (region) |
| Berretta, Julia (Epsilen Bio 202006– CEO + Genespire 202004– CEO before Cellectis 2014–201812 VP BusDev) | Chief Executive Officer (CEO) | Genespire S.r.l. | Lombardia (Lombardy) |
| Bers, George (Panomics 200604 Exec VP for Commercial Operations) | n. a. | Thermo Fisher (Group) | California (federal state) |
| Bertaïna, Frédéric (Bioxis Pharmaceuticals 202005 CEO) | Chief Executive Officer (CEO) | Bioxis Pharmaceuticals SAS | Auvergne-Rhône-Alpes (region) |
| Bertéa, Léopold (France (govt) 201511– Head of LFB Global Bioproduction division before Sanofi + Novartis) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Berteletti, Alexandre (Leman Instruments 201706) | n. a. | Leman Instruments SAS | Auvergne-Rhône-Alpes (region) |
| Berthet, Pascale (TreeFrog 202002– Chief Business Development Officer before Fujifilm Cellular Dynamics + Artelis) | Business Development Manager / Strategy Manager | TreeFrog Therapeutics (Group) | Nouvelle-Acquitaine (New Acquitaine) (region) |
| Bertholet, Clément (Calida Therapeutics 202304– CEO + Operating Partner at AdBio Partners before Thabor Therapeutics) | Chief Executive Officer (CEO) | Calida Therapeutics SAS | Île-de-France (region) |
| Berthon, Philippe (Aurgalys 201702 CEO + Founder before Vaxon Biotech + UroGene) | Chief Executive Officer (CEO) | Aurgalys SAS | Île-de-France (region) |
| Berthoux, Christophe (CiToxLab 201808– CEO Europe before Synexus 2010–2017 + Charles River 1990–2006) | Chief Executive Officer (CEO) | Synexus (Group) | North West England (region) |
| Berthuin, Jeremy (France (govt) 201701 Head of Healthcare Sector at Bpifrance) | Administrative Officer (personnel) | France (govt) | Île-de-France (region) |
| Bertram, Heinz-Jürgen (Symrise 201304 CEO) | Chief Executive Officer (CEO) | Symrise (Group) | Niedersachsen (federal state) |
| Bertrand, Claude (Servier 202310 VP of RnD + CSO before Ipsen + AstraZeneca + Pfizer + Roche + Ciba-Geigy) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Servier (Group) | Île-de-France (region) |
| Besse, Zina Affas (AXA 202204– Partner + Deputy Head Healthcare Private Equity at AXA IM Atls formerly GHIA) | Partner (venture partner) | Axa (Group) | Île-de-France (region) |
| Besserve, Rodolphe (eureKARE 202208 CEO before Managing Director at Société Générale for Biotech/Medtech) | Chief Executive Officer (CEO) | eureKARE (Group) | Luxembourg (cl=4) |
| Besson, Charles (Questel 201609 CEO) | Chief Executive Officer (CEO) | Questel (FR) | Île-de-France (region) |
| Beyen, Gil (Erytech 2012– CEO before TiGenix 201112 CBO + before CEO + Co-founder) | Chief Executive Officer (CEO) | Takeda (Group) | Belgium_o |
| Bhaman, Maina (Sofinnova Partners 201810 before Imperial Innovations 201411 Director of Healthcare Ventures) | Investment Manager | Sofinnova (Group) | Île-de-France (region) |
| Bia, Michael (RNTech 200510 CEO) | Chief Executive Officer (CEO) | RNtech (Group) | Île-de-France (region) |
| Bialojan, Siegfried (Ernst & Young) | Consultant (economic/technology) | Cap Gemini Ernst & Young (Group) | Baden-Württemberg (federal state) |
| Bidani, Nasser (KaLy-Cell 201706 Administrative Director) | President/Director/Head Business Group/Unit/Division | KaLy-Cell SARL | Grand Est (Great East) (region) |
| Bigois, Mathieu (Ponthieu Partners 201702 Founder + European Venture Partner of ABG) | Partner (venture partner) | Ponthieu Partners (FR) | Central Switzerland (region) |
| Bihain, Bernard E. (Genclis 201505 CEO + Co-Founder) | Chief Executive Officer (CEO) | Genclis SAS | Grand Est (Great East) (region) |
| Bihain, Pascale (Genclis 201907 Business Development Director) | Business Development Manager / Strategy Manager | Genclis SAS | Grand Est (Great East) (region) |
| Bikoff, Maxwell (Longitude Capital 202204 Principal) | Principal (venture capital) | Longitude Capital | California (federal state) |
| Binant, Étienne (Biom’Up 201509 CEO) | Chief Executive Officer (CEO) | Biom’Up S.A. (Euronext: BUP) | Auvergne-Rhône-Alpes (region) |
| Binder, Klaus (Coral BioNet 201107 COO of Scil Technology GmbH) | Chief Operating Officer (COO) | Coral BioNet (Group) | Bayern (federal state) |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
